Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

PARP inhibitor shows neuroprotective effects in preclinical models of ischemia

Feb. 4, 2005

BRL-52537, a kappa opioid receptor agonist, provides ischemic neuroprotection in males only

Feb. 4, 2005

Water-dispersible tablet formulations of lamotrigine patented by Ranbaxy

Feb. 3, 2005

Roche reports new adenosine A2A receptor ligands and use for Parkinson's, depression

Feb. 3, 2005

Cortex cleared for phase II Alzheimer's imaging study of CX-717

Feb. 3, 2005

Antipsychotic 5-HT1A modulators demonstrate anxiolytic properties in preclinical model

Feb. 3, 2005

Ajinomoto patents TRPV receptor ligands for treatment of pain

Feb. 2, 2005

Aromatization reported to increase the cognitive benefits of testosterone supplementation

Feb. 2, 2005

Enrollment begins in phase II study of MS-I.E.T.

Feb. 2, 2005

Two series of cannabinoid receptor modulators disclosed by Japan Tobacco

Feb. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...